PHARMACOGENOMIC VARIANTS OF CYP2C9, CYP4F2 AND VKORC1 AND ITS RELATION TO WARFARIN RESPONSE IN NATIVE OMANI PATIENTS

被引：0
|
作者：
Pathare, A. [1 ]
AlZadjali, S. [1 ]
Misquith, R. [1 ]
Gravell, D. [1 ]
Al Falahi, K. [1 ]
Al-Haddabi, H. [1 ]
Krishnamoorthy, R. [2 ]
机构：
[1] Sultan Qaboos Univ, Muscat, Oman
[2] INSERM, U763, Paris, France
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1708
引用
收藏
页码：668 / 668
页数：1
相关论文
共 50 条
  • [1] Warfarin Pharmacogenetics: Polymorphisms of the CYP2C9, CYP4F2, and VKORC1 Loci in a Genetically Admixed Omani Population
    Pathare, Anil V.
    Al Zadjali, Shoaib
    Misquith, Rhea
    Alkindi, Salam S.
    Panjwani, Vinodh
    Lapoumeroulie, Claudine
    Pravin, Sahaya
    Paldi, Andras
    Krishnamoorthy, Rajagopal
    [J]. HUMAN BIOLOGY, 2012, 84 (01) : 67 - 77
  • [2] Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey
    Kocael, Ahmet
    Eronat, Allison Pinar
    Tuzuner, Mete Bora
    Ekmekci, Ahmet
    Orhan, Ahmet Lutfullah
    Ikizceli, Ibrahim
    Yilmaz-Aydogan, Hulya
    Ozturk, Oguz
    [J]. MOLECULAR BIOLOGY REPORTS, 2019, 46 (02) : 1825 - 1833
  • [3] Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey
    Ahmet Kocael
    Allison Pınar Eronat
    Mete Bora Tüzüner
    Ahmet Ekmekçi
    Ahmet Lütfullah Orhan
    İbrahim İkizceli
    Hülya Yılmaz-Aydoğan
    Oğuz Öztürk
    [J]. Molecular Biology Reports, 2019, 46 : 1825 - 1833
  • [4] Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population
    Vear, Susan I.
    Ayers, Gregory D.
    Stein, C. Michael
    Ho, Richard H.
    [J]. BLOOD, 2012, 120 (21)
  • [5] A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 640 - 648
  • [6] CYP2C9, CYP4F2, VKORC1 Gene Polymorphism in Buryat Population
    Sambyalova, A. Yu.
    Bairova, T. A.
    Belyaeva, E. V.
    Ershova, O. A.
    Sargaeva, D. S.
    Kolesnikov, S. I.
    [J]. RUSSIAN JOURNAL OF GENETICS, 2020, 56 (12) : 1496 - 1503
  • [7] CYP2C9, CYP4F2, VKORC1 Gene Polymorphism in Buryat Population
    A. Yu. Sambyalova
    T. A. Bairova
    E. V. Belyaeva
    O. A. Ershova
    D. S. Sargaeva
    S. I. Kolesnikov
    [J]. Russian Journal of Genetics, 2020, 56 : 1496 - 1503
  • [8] The effect of polymorphisms in CYP2C9, CYP4F2, EPHX1 and VKORC1 on warfarin dose in Turkish patients
    Ozer, Mahmut
    Demirci, Yeliz
    Sarikaya, Sabit
    Karalti, Iskender
    Kaspar, Cigdem
    Hizel, Candan
    Alpan, Serdar
    Genc, Ece
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 : S125 - S125
  • [9] Study of VKORC1, CYP2C9, and CYP4F2 polymorphisms and their association with warfarin dose requirements in Egyptian patients.
    Shahin, Mohamed H.
    Khalifa, Sherief I.
    Sallam, Tarif H.
    Hammad, Lamiaa N.
    El Shafey, Mostafa
    Ali, Shawky S.
    Mohamed, Mohamed-Eslam F.
    Langaee, Taimour
    Johnson, Julie A.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1065 - 1065
  • [10] Impact of VKORC1, CYP2C9, and CYP4F2 Polymorphisms on Optimal Warfarin Dose: Does Ethnicity Matters?
    Li, Jia X.
    Kim, Moo H.
    Song, Kai
    Guo, Long Z.
    Jin, En Z.
    Kim, Soo J.
    Lee, Kwang M.
    Serebruany, Victor
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) : E461 - E468
12345